Norway / 5 Medtechs to Watch
Norway, known more for its expertise in oil and gas and marine biology than in health innovation, is home to…
EUROPE
Pricing / Italy Takes Global Transparency Lead by Forcing Pharma to Disclose Public R&D Funding
In July 2020, Italy became the first country in the world to mandate pharma companies to disclose data surrounding…
Europe / Sandoz Bolsters its Essential Medicine Manufacturing Capacity
In the wake of the COVID-19 crisis and the subsequent strain placed on medicine supply chains in Europe, Sandoz –…
Swiss-US Trade / Why an FTA Would Prevent Switzerland from ‘Falling Through the Cracks’
The USA is now Switzerland’s biggest export market and in 2019 Switzerland exported more to the US than to…
Data / Switzerland Innovation & Competitiveness Snapshot 2020
In just a few years, Switzerland has fallen from first to fifth place in the Global Competitiveness Index. The…
Poland / Top 5 Pharma Companies
Every year, Polish news magazine Wprost publishes its ranking of the top 200 Polish companies across all…
News Roundup / French Pharma August 2020
A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s…
Market Access in Switzerland / Reimbursement Delays for 76% of New Products Undermining Innovation Reputation
Switzerland, rightly regarded as one of the world’s most innovative nations, risks damaging its reputation if…
Belgium / Healthcare Snapshot 2020
An overview of health and healthcare in Belgium with data on the country’s leading causes of death,…
In Conversation
Martina Stenerdal – General Manager, PPD Scandinavia
As a worldwide research powerhouse, Sweden is benefiting from the presence of multinational clinical research organizations like PPD. Martina Stenerdal, general manager for PPD in Scandinavia, discusses the company’s 25-year presence in the Nordic region and the unparalleled advantages of conducting clinical studies in Sweden. Sweden has many startups and biotechnology companies, which offers a great window of opportunity…
Latest Reports
Focus on Switzerland
What Three Pharma Leaders Want to Share About Switzerland
PharmaBoardroom highlights three of the most enterprising and dynamic pharma…
Moving the Needle on Gender Diversity in Swiss Pharma…
While Switzerland has Europe's second-highest proportion of women in the…
Read more from Switzerland >>
Focus on Belgium
Belgium Appoints ‘Corona Commissioner’ to Coordinate…
The new Belgian government has moved to streamline its response to the COVID-19…
The Long Read: Belgium – The Multifaceted
Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the…
Read more from Belgium >>
Focus on Norway
The Woman Flying the Flag for Norwegian Pharma
Small in terms of market size and without the historic life sciences footprint…
Norway: Staking a Claim as a Pharma Research Hub
Norway, more well-known internationally as an innovation hub for oil & gas…
Read more from Norway >>
Focus on France
France: Mid-2021 for Sanofi COVID-19 Vaccine; 1 Million…
A roundup of the latest stories from French pharma, including the progress of…
French Pharma News Roundup August 2020
A roundup of some of the latest from French pharma, including Sanofi’s bumper…
Read more from France >>
News Roundup / UK Pharma May 2020
Below we highlight some recent developments in pharma and healthcare in the UK, including drug shortages in British…
Contract Manufacturing / Recipharm: Sweden's CMO Champion
Since going public five years ago, Recipharm, Sweden’s iconic indigenous contract development and manufacturing…
Sanofi / Thomas Triomphe Appointed Executive Vice President of Vaccines Unit
With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe…
CEE / Recent Developments in Latvian Pharma
Dr Valters Bolevics, CEO of the Association of International Research-based Pharmaceutical Manufacturers (SIFFA) in…
The UK / The G7’s Hottest Life Science Investment Destination?
With Brexit now confirmed, the UK government has been playing up the country’s scientific credentials. The aim is…
New Special Report on Pharma in Cyprus
With a population of just 1.2 million and a proportionately small pharmaceutical market by EU standards, Cyprus is…